Summary
- Global veterinary PoC diagnostics market projected to grow from $1.19 billion in 2026 to $1.72 billion by 2031
- Market expected to expand at a 7.7% CAGR over the forecast period
- Consumables represented the largest product segment in 2025
- Molecular diagnostics anticipated to post the fastest growth rate through 2031
- North America led the market in 2025, while Asia-Pacific is expected to see the highest CAGR
The global veterinary point-of-care (PoC) diagnostics market is projected to reach approximately $1.72 billion by 2031, according to a new report from MarketsandMarkets. The firm estimates the market will grow from $1.19 billion in 2026 at a compound annual growth rate (CAGR) of 7.7%.
The report attributes growth to increasing demand for rapid, in-clinic diagnostic testing and continued advancements in portable diagnostic technologies, including handheld analyzers, molecular diagnostics platforms, biosensors, and microfluidic systems.
Companion Animal Care Continues to Drive Demand
According to the report, companion animals accounted for 72.5% of the veterinary PoC diagnostics market in 2025, reflecting sustained investment in preventive care and faster diagnostic turnaround times in veterinary practices. Immunodiagnostics represented the largest technology segment, capturing 84.7% of market share in 2025.
MarketsandMarkets noted that consumables — including test kits, cartridges, strips, and reagents — generated the largest share of revenue because they are required for every diagnostic test performed, creating recurring demand.
Molecular Diagnostics Expected to Accelerate
The report identified molecular diagnostics as the fastest-growing technology segment during the forecast period. Researchers cited increasing adoption of portable PCR and isothermal amplification technologies for infectious disease detection and zoonotic disease monitoring.
The growing availability of cartridge-based systems and simplified testing workflows is also making molecular diagnostics more accessible in veterinary clinic and field settings, according to the report.
North America Leads While Asia-Pacific Expands Rapidly
North America accounted for the largest share of the veterinary PoC diagnostics market in 2025, supported by established veterinary healthcare infrastructure, strong pet healthcare spending, and widespread adoption of rapid diagnostics technologies.
Meanwhile, Asia-Pacific is expected to post the highest regional growth rate through 2031, with an anticipated CAGR of 9.0%.
Companies highlighted in the report include IDEXX Laboratories, Zoetis, Antech Diagnostics, Thermo Fisher Scientific, Virbac, bioMérieux, Neogen, and FUJIFILM, among others.
Information sourced from a MarketsandMarkets press release and market research report.
